IMU-201 (PD1-Vaxx)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMU-201 (PD1-Vaxx), covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer [Phase 1]